Obstetrics/Gynecology Flashcards
Breast Mass Path: Pt: Dx: Tx:
Path:
Fibrocystic breast disease MC benign lesion in breast-> fluctuating estrogen levels during menstrual cycles
Pt:
Rope-like or cobblestoning texture in bilateral breasts w/ cyclical pain associated w/ mensuration
30-50 y/o
Dx:
U/S: dense, prominent fibroglandular tissue w/ cysts but no discernible mass
Tx: Therapeutic aspiration Avoidance of trauma to breasts Wearing a supportive bra Oil of evening primrose Diet modifications: -Caffeine restriction -Low-fat diet -Decrease alcohol consumption
Breast cancer
Path:
Dx:
Tx:
Path: MC: invasive ductal carcinoma
Dx:
Mammography + core biopsy (stereotactic biopsy)
Soft tissue mass or density and clustered microcalcifications
Spiculated soft tissue mass
MC location: upper outer quadrant
Biomarker: cancer antigen 27.29
Tx:
Estrogen receptor (ER) and progesterone receptor (PR)- cell proliferation controlled by estrogen (inhibited by tamoxifen)
-Endocrine therapy: Tamoxifen, letrozole
-Chemotherapy for high-risk characteristics:
High-grade tumors, Large size (>2cm), Pathologically involved lymph nodes
ER-negative and PR-negative
Unlikely to respond to endocrine therapy
Cytotoxic chemotherapy
HER2 (human epidermal growth factor 2) +
Trastuzumab, targets HER2 receptors
PAP Smear: Negative
Neg HPV-> q3y
> 25 y/o +HPV-> repeat annually
PAP Smear: ASC-US
atypical squamous cells of undermined significance <30: repeat in 1 yr >30: HPV +: colposcopy HPV -: repeat in 3 yrs
PAP Smear: LSIL
Low grade squamous intraepithelial lesion
Colposcopy
PAP Smear: ASC-H
Atypical squamous cells cannot exclude HSIL- high grade squamous intraepithelial
Colposcopy
PAP Smear: HSIL
High grade squamous intraepithelial lesions
Colposcopy or loop excision
PAP Smear: AGC
Atypical glandular cells of undetermined significance
Colposcopy
>35: endometrial bx
OCPs
MOA
Contraindications:
MOA:
Progestin: Suppression of LH-> inhibits ovulation, Thickening of cervical mucus, Altered fallopian tube peristalsis
Estrogen: Suppressed FSH-> prevents development of dominant follicle, Potentiates progestin effects, Primarily cycle control
Contraindications: Epilepsy Breastfeeding High risk for VTE Morbid obesity severe vascular HA (migraine) DM Severe HTN
Progestin
Indications
MOA
Indication: breast feeding, cannot take estrogen
MOA: thickening of cervical mucus
Cystocele Path: Pt: Dx: Tx:
Path: Posterior bladder herniating into the anterior vagina
Pt: Incontinence
Dx: Speculum exam-> anterior bulge in vagina
Tx:
Pelvic floor muscle training
Vaginal pessary
Colporrhaphy: surgical repair of defect in vaginal wall
Dysfunctional uterine bleeding
Path:
Dx:
Tx:
Path:
Chronic anovulation (90%):
disruption of hypothalamus-pituitary axis (teens, perimenopausal)
Unopposed estrogen: inc endometrial overgrowth
Ovulatory (10%)
Dx: DOE
hormone levels, TV U/S,
endometrial bx: endometrial stripe >4mm on U/S, women >35yrs
Tx:
Acute severe bleeding:. High-dose IV estrogen or high dose OCPs. Reduce dose as bleeding improves, D&C may be used if IV estrogen fails
Anovulatory (90%)
OCPs 1st line, Progesterone (medroxyprogesterone): if estrogen is contraindicated, GnRH agonists (leuprolide): causes temporary amenorrhea (if given in continuous fashion)
Ovulatory (10%)
OCPs: regulate cycles, thins endometrial lining
Progesterone: orally or IUD (mirena reduced bleeding in 79-94%)
GnRH agonists: Leuprolide w/ add-back progesterone (to reduce the S/E of leuprolide)
Surgery: hysterectomy, endometrial ablation
Dysmenorrhea
Path:
Tx:
Painful menstruation that affects normal activities
Path:
Primary: not due to pelvic pathology
Inc prostaglandins -> painful uterine muscle wall activity.
Secondary: due to pelvic pathology
endometriosis, adenomyosis, leiomyomas, adhesions, PID
Tx:
NSAIDs
Ovulation suppression
Laparoscopy
Intrauterine pregnancy
Dx:
Yolk sac within a gestational sac
intrauterine fetal pole
Intrauterine fetal heart activity
TVUS >38 days after LMP or beta-hCG >1500
Abdominal US >45 days after LMP or beta-hCG >4000
Menopause
Dx:
Tx:
Dx: Inc FSH/LH dec estrogen
Tx:
hot flashes: estrogen, progesterone, clonidine, SSRIs
Vaginal atrophy: estrogen
Osteoporosis prevention: calcium + vit D, weight bearing exercise, bisphosphonates, calcitonin
RTC:
Estrogen only:
pros: most effective tx sx, no inc risk of breast cancer
cons: inc risk endometrial cancer, VTE, liver disease
E + P:
pros: sx relief, dec heart and stroke risk, dec osteoporosis, dec dementia, protective against endometrial cancer
cons: VTE, slight increase risk of breast cancer